BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17898570)

  • 1. Evidence based therapeutic apheresis in autoimmune and other hemolytic anemias.
    McLeod BC
    Curr Opin Hematol; 2007 Nov; 14(6):647-54. PubMed ID: 17898570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in the immune hemolytic anemias and immunologic thrombocytopenic purpura.
    Brooks BD; Steane EA; Sheehan RG; Frenkel EP
    Prog Clin Biol Res; 1982; 106():317-29. PubMed ID: 6757948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006.
    Nguyen L; Li X; Duvall D; Terrell DR; Vesely SK; George JN
    Transfusion; 2008 Feb; 48(2):349-57. PubMed ID: 18028271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apheresis for renal disease.
    Kaplan AA
    Ther Apher; 2001 Apr; 5(2):134-41. PubMed ID: 11354298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for Apheresis.
    Klein HG; Balow JE; Dau PC; Hamburger MI; Leitman SF; Pineda AA; Tindall RS
    J Clin Apher; 1986; 3(1):i-vi, 1-92. PubMed ID: 3081494
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic apheresis: where we've been and where we are going.
    Vogler WR
    Prog Clin Biol Res; 1982; 106():1-13. PubMed ID: 6757935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection.
    George JN; Kremer Hovinga JA; Terrell DR; Vesely SK; Lämmle B
    Eur J Haematol; 2008 Apr; 80(4):277-86. PubMed ID: 18221388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in the treatment of autoimmune haematological disorders.
    Garvey B
    Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.
    Linenberger ML; Price TH
    J Intensive Care Med; 2005; 20(2):88-103. PubMed ID: 15855221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple autoimmune syndrome: succession of bullous pemphigoid, endocapillary proliferative glomerulonephritis, Guillain-Barré syndrome and idiopathic thrombocytopenic purpura: cascade-apheresis or "the panacea"?].
    Branger B; Zabadani B; Vécina F; Balducchi JP; Fourcade J
    Ann Med Interne (Paris); 1994; 145(5):382-3. PubMed ID: 7985956
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic anemia.
    Dhaliwal G; Cornett PA; Tierney LM
    Am Fam Physician; 2004 Jun; 69(11):2599-606. PubMed ID: 15202694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of therapeutic plasma exchange in hematology.
    Radović M; Balint B; Tiska-Rudman L; Milenković L; Taseski J
    Transfus Sci; 1994 Dec; 15(4):481-5. PubMed ID: 10155567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis activity in Venezuela.
    Saltiel C
    J Clin Apher; 2005 Jul; 20(2):95-100. PubMed ID: 15880361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic apheresis in autoimmune and rheumatic diseases.
    Koo AP
    J Clin Apher; 2000; 15(1-2):18-27. PubMed ID: 10767049
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange in refractory autoimmune anemia in a child with systemic vasculitis associated with homozygote beta thalassemia.
    Beşbaş N; Ozen S; Bakkaloğlu A; Gürgey A; Kanra T; Saatçi U
    Turk J Pediatr; 1994; 36(4):337-40. PubMed ID: 7825242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concepts and goals in the management of transfusional iron overload.
    Porter JB
    Am J Hematol; 2007 Dec; 82(12 Suppl):1136-9. PubMed ID: 17968973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatment options for immune-mediated hematological disorders.
    Dierickx D; De Rycke A; Vanderschueren S; Delannoy A
    Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic apheresis in neurology critical care.
    Natarajan N; Weinstein R
    J Intensive Care Med; 2005; 20(4):212-25. PubMed ID: 16061904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange.
    McLeod BC
    Best Pract Res Clin Haematol; 2006; 19(1):157-67. PubMed ID: 16377548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails.
    McLeod BC
    J Crit Illn; 1991 May; 6(5):487-95. PubMed ID: 10147917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.